ES2084972T3 - Compuestos de imidazol, su preparacion y su uso como bloqueadores de los canales de calcio. - Google Patents

Compuestos de imidazol, su preparacion y su uso como bloqueadores de los canales de calcio.

Info

Publication number
ES2084972T3
ES2084972T3 ES92610081T ES92610081T ES2084972T3 ES 2084972 T3 ES2084972 T3 ES 2084972T3 ES 92610081 T ES92610081 T ES 92610081T ES 92610081 T ES92610081 T ES 92610081T ES 2084972 T3 ES2084972 T3 ES 2084972T3
Authority
ES
Spain
Prior art keywords
blockers
preparation
calcium channels
imidazole compounds
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92610081T
Other languages
English (en)
Inventor
Oskar Axelsson
Thaning
Peter Moldt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NTG Nordic Transport Group AS
Original Assignee
Neurosearch AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch AS filed Critical Neurosearch AS
Application granted granted Critical
Publication of ES2084972T3 publication Critical patent/ES2084972T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Resins (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Dental Preparations (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Lubricants (AREA)
  • Polyesters Or Polycarbonates (AREA)

Abstract

EL PRESENTE INVENTO COMPRENDE COMPUESTO DE LA FORMULA DONDE R Y R'' SON INDEPENDIENTEMENTE ENTRE SI HIDROGENO O ALQUILO, O R Y R'' CONJUNTAMENTE FORMAN UN CADENA DE ALQUILENO DE 3 A 6 ELEMENTOS; N ES 1 O 2; R1 ES FENILO QUE PUEDE ESTAR SUSTITUIDO UNA O MAS VECES CON HALOGENO, CF3, ALCOXI, ALQUILO O AMINO; Y R4,R5,R6 Y R7 INDEPENDIENTEMENTE ENTRE SI SON HIDROGENO, HALOGENO, AMINO, CF3, ALQUILO O ALCOXI; O UNA SAL DE ADICION FARMACEUTICAMENTE ACEPTABLE CONSIGUIENTE. LOS COMPUESTOS SON UTILES COMO FARMACOS, POR EJEMPLO EN EL TRATAMIENTO DE ISQUEMIA, ANOXIA, MIGRAÑA Y PSICOSIS.
ES92610081T 1991-12-03 1992-11-20 Compuestos de imidazol, su preparacion y su uso como bloqueadores de los canales de calcio. Expired - Lifetime ES2084972T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80175491A 1991-12-03 1991-12-03

Publications (1)

Publication Number Publication Date
ES2084972T3 true ES2084972T3 (es) 1996-05-16

Family

ID=25181970

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92610081T Expired - Lifetime ES2084972T3 (es) 1991-12-03 1992-11-20 Compuestos de imidazol, su preparacion y su uso como bloqueadores de los canales de calcio.

Country Status (15)

Country Link
US (1) US5314903A (es)
EP (1) EP0545845B1 (es)
JP (1) JPH072796A (es)
KR (1) KR100220303B1 (es)
AT (1) ATE134622T1 (es)
AU (1) AU649899B2 (es)
CA (1) CA2084233A1 (es)
DE (1) DE69208604T2 (es)
DK (1) DK0545845T3 (es)
ES (1) ES2084972T3 (es)
FI (1) FI925501A (es)
GR (1) GR3019439T3 (es)
NO (1) NO300832B1 (es)
NZ (1) NZ245287A (es)
ZA (1) ZA929268B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154092D0 (da) * 1992-12-23 1992-12-23 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
JP2002519412A (ja) * 1998-07-02 2002-07-02 ニューロサーチ、アクティーゼルスカブ カリウムチャンネル遮断剤
US6194447B1 (en) 1998-07-02 2001-02-27 Neurosearch A/S Bis (benzimidazole) derivatives serving as potassium blocking agents
EP1144387A1 (en) * 1998-12-04 2001-10-17 Neurosearch A/S New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
WO2004064835A1 (en) * 2003-01-17 2004-08-05 Neurosearch A/S Use of ion channel modulating agents for treating pain
US20050159403A1 (en) * 2003-04-22 2005-07-21 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of central nervous system damage
WO2004093813A2 (en) * 2003-04-22 2004-11-04 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders
US7166603B2 (en) 2003-07-23 2007-01-23 Bristol-Myers Squibb Co. Dihydropyrimidone inhibitors of calcium channel function
WO2005007124A2 (en) 2003-07-23 2005-01-27 Bristol-Myers Squibb Company Substituted dihydropyrimidine inhibitors of calcium channel function
DE10342503A1 (de) * 2003-09-12 2005-04-14 Merck Patent Gmbh Benzyl-Benzimidazolylderivate
US7504431B2 (en) 2004-04-16 2009-03-17 Bristol-Myers Squibb Company Sulfonyl amide inhibitors of calcium channel function
US8921406B2 (en) 2005-08-21 2014-12-30 AbbVie Deutschland GmbH & Co. KG 5-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptors
GB0715103D0 (en) * 2007-08-03 2007-09-12 Lectus Therapeutics Ltd Calcium ion channel modulators and uses thereof
US10501421B1 (en) * 2017-01-27 2019-12-10 Vanderbilt University Substituted benzimidazoles as modulators of Ras signaling

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004016A (en) * 1975-08-11 1977-01-18 E. R. Squibb & Sons, Inc. Amino-benzimidazole derivatives
NZ232396A (en) * 1989-02-10 1991-07-26 Merrell Dow Pharma 2-(diphenylalkylamino) -1,3 nn heterocyclic compounds and pharmaceutical compositions
DE3928177A1 (de) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5210091A (en) * 1991-06-24 1993-05-11 Neurosearch A/S Imidazole compounds and their use

Also Published As

Publication number Publication date
ATE134622T1 (de) 1996-03-15
CA2084233A1 (en) 1993-06-04
DE69208604D1 (de) 1996-04-04
NZ245287A (en) 1995-04-27
FI925501A (fi) 1993-06-04
GR3019439T3 (en) 1996-06-30
KR100220303B1 (ko) 1999-09-15
DE69208604T2 (de) 1996-09-05
DK0545845T3 (da) 1996-08-05
NO924646D0 (no) 1992-12-02
AU2965192A (en) 1993-06-10
FI925501A0 (fi) 1992-12-03
AU649899B2 (en) 1994-06-02
NO924646L (no) 1993-06-04
US5314903A (en) 1994-05-24
JPH072796A (ja) 1995-01-06
ZA929268B (en) 1993-06-29
EP0545845B1 (en) 1996-02-28
EP0545845A1 (en) 1993-06-09
NO300832B1 (no) 1997-08-04

Similar Documents

Publication Publication Date Title
ES2084972T3 (es) Compuestos de imidazol, su preparacion y su uso como bloqueadores de los canales de calcio.
DE69208868D1 (de) 5-heteroyl indol derivate
FI935801A (fi) Imidatsoliyhdisteitä, niiden valmistus ja käyttö
YU17591A (sh) Triazolni fungicidni agensi
EA199800702A1 (ru) Хиноксалиндионы
FI840237A (fi) Antifungicida triazolfoereningar.
FI935823A0 (fi) Hypoglykemiska tiozolidindionfoereningar
DE69302087T2 (de) Trazodone alkyl derivate mit zns wirkung
ES2072521T5 (es) Compuestos intermedios de la astaxantina.
BR9307392A (pt) Benzimidazóis substituìdos
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.
ECSP920887A (es) Fungicidas de pirazol carboxianilida

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 545845

Country of ref document: ES